-
1
-
-
84923949767
-
Nigro-striate and cerebello-nigro-striate degeneration (Clinical uniqueness and pathological variability of presenile degeneration of the extrapyramidal rigidity type)
-
Adams M.R., Van Bogaert L., van der Eecken H. Nigro-striate and cerebello-nigro-striate degeneration (Clinical uniqueness and pathological variability of presenile degeneration of the extrapyramidal rigidity type). Psychiatr Neurol (Basel) 1961, 142:219-259.
-
(1961)
Psychiatr Neurol (Basel)
, vol.142
, pp. 219-259
-
-
Adams, M.R.1
Van Bogaert, L.2
van der Eecken, H.3
-
2
-
-
0029593355
-
Effects of the peptide release inhibitor octreotide on daytime hypotension and on nocturnal hypertension in primary autonomic failure
-
Alam M., Smith G., Bleasdale-Barr K., et al. Effects of the peptide release inhibitor octreotide on daytime hypotension and on nocturnal hypertension in primary autonomic failure. J Hypertens 1995, 13:1664-1669.
-
(1995)
J Hypertens
, vol.13
, pp. 1664-1669
-
-
Alam, M.1
Smith, G.2
Bleasdale-Barr, K.3
-
3
-
-
70349578343
-
Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy
-
Al-Chalabi A., Durr A., Wood N.W., et al. Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS One 2009, 4:e7114.
-
(2009)
PLoS One
, vol.4
-
-
Al-Chalabi, A.1
Durr, A.2
Wood, N.W.3
-
4
-
-
56249099099
-
Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report
-
Apostolidis A., Dasgupta P., Denys P., et al. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol 2009, 55:100-119.
-
(2009)
Eur Urol
, vol.55
, pp. 100-119
-
-
Apostolidis, A.1
Dasgupta, P.2
Denys, P.3
-
5
-
-
0028323244
-
Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases
-
Beck R.O., Betts C.D., Fowler C.J. Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. J Urol 1994, 151:1336-1341.
-
(1994)
J Urol
, vol.151
, pp. 1336-1341
-
-
Beck, R.O.1
Betts, C.D.2
Fowler, C.J.3
-
6
-
-
0031936544
-
Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure
-
Benarroch E.E., Smithson I.L., Low P.A., et al. Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure. Ann Neurol 1998, 43:156-163.
-
(1998)
Ann Neurol
, vol.43
, pp. 156-163
-
-
Benarroch, E.E.1
Smithson, I.L.2
Low, P.A.3
-
7
-
-
33749491569
-
Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy
-
Benarroch E.E., Schmeichel A.M., Sandroni P., et al. Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy. Brain 2006, 129:2688-2696.
-
(2006)
Brain
, vol.129
, pp. 2688-2696
-
-
Benarroch, E.E.1
Schmeichel, A.M.2
Sandroni, P.3
-
8
-
-
33646167623
-
Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease
-
Benarroch E.E., Schmeichel A.M., Sandroni P., et al. Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease. Neurology 2006, 66:378-383.
-
(2006)
Neurology
, vol.66
, pp. 378-383
-
-
Benarroch, E.E.1
Schmeichel, A.M.2
Sandroni, P.3
-
9
-
-
33751202436
-
Involvement of hypocretin neurons in multiple system atrophy
-
Benarroch E.E., Schmeichel A.M., Sandroni P., et al. Involvement of hypocretin neurons in multiple system atrophy. Acta Neuropathol 2007, 113:75-80.
-
(2007)
Acta Neuropathol
, vol.113
, pp. 75-80
-
-
Benarroch, E.E.1
Schmeichel, A.M.2
Sandroni, P.3
-
10
-
-
58849122658
-
Riluzole treatment survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study
-
Bensimon G., Ludolph A., Agid Y., et al. Riluzole treatment survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 2009, 132:156-171.
-
(2009)
Brain
, vol.132
, pp. 156-171
-
-
Bensimon, G.1
Ludolph, A.2
Agid, Y.3
-
11
-
-
53649086350
-
Transcranial sonography in movement disorders
-
Berg D., Godau J., Walter U. Transcranial sonography in movement disorders. Lancet Neurol 2008, 7:1044-1055.
-
(2008)
Lancet Neurol
, vol.7
, pp. 1044-1055
-
-
Berg, D.1
Godau, J.2
Walter, U.3
-
12
-
-
0030695277
-
Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County Minnesota 1976 to 1990
-
Bower J.H., Maraganore D.M., McDonnell S.K., et al. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County Minnesota 1976 to 1990. Neurology 1997, 49:1284-1288.
-
(1997)
Neurology
, vol.49
, pp. 1284-1288
-
-
Bower, J.H.1
Maraganore, D.M.2
McDonnell, S.K.3
-
13
-
-
67651146706
-
Proposed neuroimaging criteria for the diagnosis of multiple system atrophy
-
Brooks D.J., Seppi K. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord 2009, 24:949-964.
-
(2009)
Mov Disord
, vol.24
, pp. 949-964
-
-
Brooks, D.J.1
Seppi, K.2
-
14
-
-
33646114508
-
Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline
-
Casarejos M.J., Menendez J., Solano R.M., et al. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. J Neurochem 2006, 97:934-946.
-
(2006)
J Neurochem
, vol.97
, pp. 934-946
-
-
Casarejos, M.J.1
Menendez, J.2
Solano, R.M.3
-
15
-
-
27744545322
-
Brain SPECT imaging in multiple system atrophy
-
Cilia R., Marotta G., Benti R., et al. Brain SPECT imaging in multiple system atrophy. J Neural Transm 2005, 112:1635-1645.
-
(2005)
J Neural Transm
, vol.112
, pp. 1635-1645
-
-
Cilia, R.1
Marotta, G.2
Benti, R.3
-
16
-
-
0029975120
-
Amantadine in parkinsonian patients unresponsive to levodopa: a pilot study
-
Colosimo C., Merello M., Pontieri F.E. Amantadine in parkinsonian patients unresponsive to levodopa: a pilot study. J Neurol 1996, 243:422-425.
-
(1996)
J Neurol
, vol.243
, pp. 422-425
-
-
Colosimo, C.1
Merello, M.2
Pontieri, F.E.3
-
17
-
-
0029904204
-
Consensus statement on the definition of orthostatic hypotension pure autonomic failure and multiple system atrophy
-
Consensus Committee of the American Autonomic Society and the American Academy of Neurology [No authors listed]
-
Consensus Committee of the American Autonomic Society and the American Academy of Neurology [No authors listed] Consensus statement on the definition of orthostatic hypotension pure autonomic failure and multiple system atrophy. Neurology 1996, 46:1470.
-
(1996)
Neurology
, vol.46
, pp. 1470
-
-
-
18
-
-
0002949303
-
The neuropathology and neurochemistry of multiple system atrophy
-
Oxford University Press, Oxford, C.J. Mathias, R. Bannister (Eds.)
-
Daniel S. The neuropathology and neurochemistry of multiple system atrophy. Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System 1999, Oxford University Press, Oxford. C.J. Mathias, R. Bannister (Eds.).
-
(1999)
Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System
-
-
Daniel, S.1
-
19
-
-
34548172773
-
Different species of alpha-synuclein oligomers induce calcium influx and seeding
-
Danzer K.M., Haasen D., Karow A.R., et al. Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci 2007, 27:9220-9232.
-
(2007)
J Neurosci
, vol.27
, pp. 9220-9232
-
-
Danzer, K.M.1
Haasen, D.2
Karow, A.R.3
-
20
-
-
70349223775
-
Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology
-
Danzer K.M., Krebs S.K., Wolff M., et al. Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J Neurochem 2009, 111:192-203.
-
(2009)
J Neurochem
, vol.111
, pp. 192-203
-
-
Danzer, K.M.1
Krebs, S.K.2
Wolff, M.3
-
21
-
-
35348971460
-
Assessment of autonomic dysfunction of multiple system atrophy with laryngeal abductor paralysis as an early manifestation
-
Deguchi K., Ikeda K., Shimamura M., et al. Assessment of autonomic dysfunction of multiple system atrophy with laryngeal abductor paralysis as an early manifestation. Clin Neurol Neurosurg 2007, 109:892-895.
-
(2007)
Clin Neurol Neurosurg
, vol.109
, pp. 892-895
-
-
Deguchi, K.1
Ikeda, K.2
Shimamura, M.3
-
23
-
-
75749146196
-
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11).C] (R).-PK11195 PET (MEMSA-trial)
-
Dodel R., Spottke A., Gerhard A., et al. Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11).C] (R).-PK11195 PET (MEMSA-trial). Mov Disord 2010, 25:97-107.
-
(2010)
Mov Disord
, vol.25
, pp. 97-107
-
-
Dodel, R.1
Spottke, A.2
Gerhard, A.3
-
24
-
-
20444436869
-
FDG PET in the differential diagnosis of parkinsonian disorders
-
Eckert T., Barnes A., Dhawan V., et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 2005, 26:912-921.
-
(2005)
Neuroimage
, vol.26
, pp. 912-921
-
-
Eckert, T.1
Barnes, A.2
Dhawan, V.3
-
25
-
-
65349090181
-
Acute haemodynamic response to sleeping head-up at 6 inches in older inpatients
-
Fan C.W., Gasparro D., Crowley V., et al. Acute haemodynamic response to sleeping head-up at 6 inches in older inpatients. Clin Auton Res 2009, 19:51-57.
-
(2009)
Clin Auton Res
, vol.19
, pp. 51-57
-
-
Fan, C.W.1
Gasparro, D.2
Crowley, V.3
-
26
-
-
18744431093
-
Investigation and management of neurogenic bladder dysfunction
-
Fowler C.J., O'Malley K.J. Investigation and management of neurogenic bladder dysfunction. J Neurol Neurosurg Psychiatry 2003, 74(Suppl 4):iv27-iv31.
-
(2003)
J Neurol Neurosurg Psychiatry
, vol.74
, Issue.SUPPL 4
-
-
Fowler, C.J.1
O'Malley, K.J.2
-
27
-
-
43449134405
-
Current pharmacologic treatment for orthostatic hypotension
-
Freeman R. Current pharmacologic treatment for orthostatic hypotension. Clin Auton Res 2008, 18(Suppl 1):14-18.
-
(2008)
Clin Auton Res
, vol.18
, Issue.SUPPL 1
, pp. 14-18
-
-
Freeman, R.1
-
28
-
-
33748778742
-
Paroxetine treatment improves motor symptoms in patients with multiple system atrophy
-
Friess E., Kuempfel T., Modell S., et al. Paroxetine treatment improves motor symptoms in patients with multiple system atrophy. Parkinsonism Relat Disord 2006, 12:432-437.
-
(2006)
Parkinsonism Relat Disord
, vol.12
, pp. 432-437
-
-
Friess, E.1
Kuempfel, T.2
Modell, S.3
-
29
-
-
33644947758
-
Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG)
-
Geser F., Wenning G.K., Seppi K., et al. Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG). Mov Disord 2006, 21:179-186.
-
(2006)
Mov Disord
, vol.21
, pp. 179-186
-
-
Geser, F.1
Wenning, G.K.2
Seppi, K.3
-
30
-
-
69749115645
-
Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy
-
Giannantoni A., Rossi A., Mearini E., et al. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy. J Urol 2009, 182:1453-1457.
-
(2009)
J Urol
, vol.182
, pp. 1453-1457
-
-
Giannantoni, A.1
Rossi, A.2
Mearini, E.3
-
31
-
-
33746817127
-
Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance
-
Gibbons C.H., Freeman R. Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology 2006, 67:28-32.
-
(2006)
Neurology
, vol.67
, pp. 28-32
-
-
Gibbons, C.H.1
Freeman, R.2
-
32
-
-
0023855143
-
Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography
-
Gilman S., Markel D.S., Koeppe R.A., et al. Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography. Ann Neurol 1988, 23:223-230.
-
(1988)
Ann Neurol
, vol.23
, pp. 223-230
-
-
Gilman, S.1
Markel, D.S.2
Koeppe, R.A.3
-
33
-
-
0032435329
-
Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology
-
Gilman S., Low P., Quinn N., et al. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res 1998, 8:359-362.
-
(1998)
Clin Auton Res
, vol.8
, pp. 359-362
-
-
Gilman, S.1
Low, P.2
Quinn, N.3
-
34
-
-
52449086856
-
Second consensus statement on the diagnosis of multiple system atrophy
-
Gilman S., Wenning G.K., Low P.A., et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71:670-676.
-
(2008)
Neurology
, vol.71
, pp. 670-676
-
-
Gilman, S.1
Wenning, G.K.2
Low, P.A.3
-
35
-
-
0021188797
-
The pharmacology of olivopontocerebellar atrophy
-
Goetz C.G., Tanner C.M., Klawans H.L. The pharmacology of olivopontocerebellar atrophy. Adv Neurol 1984, 41:143-148.
-
(1984)
Adv Neurol
, vol.41
, pp. 143-148
-
-
Goetz, C.G.1
Tanner, C.M.2
Klawans, H.L.3
-
36
-
-
0014469501
-
Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy
-
Graham J.G., Oppenheimer D.R. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969, 32:28-34.
-
(1969)
J Neurol Neurosurg Psychiatry
, vol.32
, pp. 28-34
-
-
Graham, J.G.1
Oppenheimer, D.R.2
-
37
-
-
0141566414
-
Controlled double-blind multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability
-
Halaska M., Ralph G., Wiedemann A., et al. Controlled double-blind multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability. World J Urol 2003, 20:392-399.
-
(2003)
World J Urol
, vol.20
, pp. 392-399
-
-
Halaska, M.1
Ralph, G.2
Wiedemann, A.3
-
38
-
-
34247168008
-
Multiplex families with multiple system atrophy
-
Hara K., Momose Y., Tokiguchi S., et al. Multiplex families with multiple system atrophy. Arch Neurol 2007, 64:545-551.
-
(2007)
Arch Neurol
, vol.64
, pp. 545-551
-
-
Hara, K.1
Momose, Y.2
Tokiguchi, S.3
-
39
-
-
0037047003
-
Brain-specific p25 protein binds to tubulin and microtubules and induces aberrant microtubule assemblies at substoichiometric concentrations
-
Hlavanda E., Kovacs J., Olah J., et al. Brain-specific p25 protein binds to tubulin and microtubules and induces aberrant microtubule assemblies at substoichiometric concentrations. Biochemistry 2002, 41:8657-8664.
-
(2002)
Biochemistry
, vol.41
, pp. 8657-8664
-
-
Hlavanda, E.1
Kovacs, J.2
Olah, J.3
-
40
-
-
34447105342
-
Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind placebo-controlled study
-
Holmberg B., Johansson J.O., Poewe W., et al. Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind placebo-controlled study. Mov Disord 2007, 22:1138-1144.
-
(2007)
Mov Disord
, vol.22
, pp. 1138-1144
-
-
Holmberg, B.1
Johansson, J.O.2
Poewe, W.3
-
41
-
-
0036305705
-
Longitudinal MRI study of multiple system atrophy - when do the findings appear and what is the course?
-
Horimoto Y., Aiba I., Yasuda T., et al. Longitudinal MRI study of multiple system atrophy - when do the findings appear and what is the course?. J Neurol 2002, 249:847-854.
-
(2002)
J Neurol
, vol.249
, pp. 847-854
-
-
Horimoto, Y.1
Aiba, I.2
Yasuda, T.3
-
42
-
-
0034892569
-
Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension
-
Hussain I.F., Brady C.M., Swinn M.J., et al. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry 2001, 71:371-374.
-
(2001)
J Neurol Neurosurg Psychiatry
, vol.71
, pp. 371-374
-
-
Hussain, I.F.1
Brady, C.M.2
Swinn, M.J.3
-
43
-
-
3342983747
-
Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy
-
Iranzo A., Santamaria J., Tolosa E., et al. Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy. Neurology 2004, 63:930-932.
-
(2004)
Neurology
, vol.63
, pp. 930-932
-
-
Iranzo, A.1
Santamaria, J.2
Tolosa, E.3
-
44
-
-
33745838248
-
Incomplete emptying and urinary retention in multiple-system atrophy: when does it occur and how do we manage it?
-
Ito T., Sakakibara R., Yasuda K., et al. Incomplete emptying and urinary retention in multiple-system atrophy: when does it occur and how do we manage it?. Mov Disord 2006, 21:816-823.
-
(2006)
Mov Disord
, vol.21
, pp. 816-823
-
-
Ito, T.1
Sakakibara, R.2
Yasuda, K.3
-
45
-
-
0027291916
-
Neurogenic orthostatic hypotension: a double-blind placebo-controlled study with midodrine
-
Jankovic J., Gilden J.L., Hiner B.C., et al. Neurogenic orthostatic hypotension: a double-blind placebo-controlled study with midodrine. Am J Med 1993, 95:38-48.
-
(1993)
Am J Med
, vol.95
, pp. 38-48
-
-
Jankovic, J.1
Gilden, J.L.2
Hiner, B.C.3
-
46
-
-
33745351080
-
P25alpha immunoreactivity in multiple system atrophy and Parkinson disease
-
Jellinger K.A. P25alpha immunoreactivity in multiple system atrophy and Parkinson disease. Acta Neuropathol 2006, 112:112.
-
(2006)
Acta Neuropathol
, vol.112
, pp. 112
-
-
Jellinger, K.A.1
-
47
-
-
26444610170
-
Grading of neuropathology in multiple system atrophy: proposal for a novel scale
-
Jellinger K.A., Seppi K., Wenning G.K. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 2005, 20(Suppl 12):S29-S36.
-
(2005)
Mov Disord
, vol.20
, Issue.SUPPL 12
-
-
Jellinger, K.A.1
Seppi, K.2
Wenning, G.K.3
-
48
-
-
43449135636
-
L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience
-
Kaufmann H. L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience. Clin Auton Res 2008, 18(Suppl 1):19-24.
-
(2008)
Clin Auton Res
, vol.18
, Issue.SUPPL 1
, pp. 19-24
-
-
Kaufmann, H.1
-
49
-
-
24944446759
-
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy
-
Klos K.J., Bower J.H., Josephs K.A., et al. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 2005, 11:381-386.
-
(2005)
Parkinsonism Relat Disord
, vol.11
, pp. 381-386
-
-
Klos, K.J.1
Bower, J.H.2
Josephs, K.A.3
-
50
-
-
33846179348
-
Progression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairment
-
Kollensperger M., Stampfer-Kountchev M., Seppi K., et al. Progression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairment. Eur J Neurol 2007, 14:66-72.
-
(2007)
Eur J Neurol
, vol.14
, pp. 66-72
-
-
Kollensperger, M.1
Stampfer-Kountchev, M.2
Seppi, K.3
-
51
-
-
78349241725
-
Presentation, diagnosis and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry
-
Kollensperger M., Geser F., Ndayisaba J.P., et al. Presentation, diagnosis and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord 2010, 25:2604-2612.
-
(2010)
Mov Disord
, vol.25
, pp. 2604-2612
-
-
Kollensperger, M.1
Geser, F.2
Ndayisaba, J.P.3
-
52
-
-
43249114934
-
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease
-
Kordower J.H., Chu Y., Hauser R.A., et al. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 2008, 14:504-506.
-
(2008)
Nat Med
, vol.14
, pp. 504-506
-
-
Kordower, J.H.1
Chu, Y.2
Hauser, R.A.3
-
53
-
-
61449216234
-
Transplanted dopaminergic neurons develop PD pathologic changes: a second case report
-
Kordower J.H., Chu Y., Hauser R.A., et al. Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov Disord 2008, 23:2303-2306.
-
(2008)
Mov Disord
, vol.23
, pp. 2303-2306
-
-
Kordower, J.H.1
Chu, Y.2
Hauser, R.A.3
-
54
-
-
33846558382
-
The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases
-
Kovacs G.G., Gelpi E., Lehotzky A., et al. The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases. Acta Neuropathol 2007, 113:153-161.
-
(2007)
Acta Neuropathol
, vol.113
, pp. 153-161
-
-
Kovacs, G.G.1
Gelpi, E.2
Lehotzky, A.3
-
55
-
-
0030633688
-
Medial pallidotomy in late-stage Parkinson's disease and striatonigral degeneration
-
Lang A.E., Lozano A., Duff J., et al. Medial pallidotomy in late-stage Parkinson's disease and striatonigral degeneration. Adv Neurol 1997, 74:199-211.
-
(1997)
Adv Neurol
, vol.74
, pp. 199-211
-
-
Lang, A.E.1
Lozano, A.2
Duff, J.3
-
56
-
-
42349097728
-
Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy
-
Lee P.H., Kim J.W., Bang O.Y., et al. Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin Pharmacol Ther 2008, 83:723-730.
-
(2008)
Clin Pharmacol Ther
, vol.83
, pp. 723-730
-
-
Lee, P.H.1
Kim, J.W.2
Bang, O.Y.3
-
57
-
-
67651154483
-
Serum cholesterol levels and the risk of multiple system atrophy: a case-control study
-
Lee P.H., Lim T.S., Shin H.W., et al. Serum cholesterol levels and the risk of multiple system atrophy: a case-control study. Mov Disord 2009, 24:752-758.
-
(2009)
Mov Disord
, vol.24
, pp. 752-758
-
-
Lee, P.H.1
Lim, T.S.2
Shin, H.W.3
-
58
-
-
84864488997
-
A randomized trial of mesenchymal stem cells in multiple system atrophy
-
Lee P.H., Lee J.E., Kim H.S., et al. A randomized trial of mesenchymal stem cells in multiple system atrophy. Ann Neurol. 2012, 72:32-40.
-
(2012)
Ann Neurol.
, vol.72
, pp. 32-40
-
-
Lee, P.H.1
Lee, J.E.2
Kim, H.S.3
-
59
-
-
0019488484
-
The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy-Drager syndrome)
-
Lees A.J., Bannister R. The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy-Drager syndrome). J Neurol Neurosurg Psychiatry 1981, 44:347-351.
-
(1981)
J Neurol Neurosurg Psychiatry
, vol.44
, pp. 347-351
-
-
Lees, A.J.1
Bannister, R.2
-
60
-
-
4444223568
-
Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report
-
Lezcano E., Gomez-Esteban J.C., Zarranz J.J., et al. Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report. Mov Disord 2004, 19:973-977.
-
(2004)
Mov Disord
, vol.19
, pp. 973-977
-
-
Lezcano, E.1
Gomez-Esteban, J.C.2
Zarranz, J.J.3
-
61
-
-
43249110200
-
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
-
Li J., Englund Y.E., Holton J.L., et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 2008, 14:501-503.
-
(2008)
Nat Med
, vol.14
, pp. 501-503
-
-
Li, J.1
Englund, Y.E.2
Holton, J.L.3
-
62
-
-
20044383388
-
P25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies
-
Lindersson E., Lundvig D., Petersen C., et al. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. J Biol Chem 2005, 280:5703-5715.
-
(2005)
J Biol Chem
, vol.280
, pp. 5703-5715
-
-
Lindersson, E.1
Lundvig, D.2
Petersen, C.3
-
63
-
-
67049100869
-
Prospective differentiation of multiple system atrophy from Parkinson disease with and without autonomic failure
-
Lipp A., Sandroni P., Ahlskog J.E., et al. Prospective differentiation of multiple system atrophy from Parkinson disease with and without autonomic failure. Arch Neurol 2009, 66:742-750.
-
(2009)
Arch Neurol
, vol.66
, pp. 742-750
-
-
Lipp, A.1
Sandroni, P.2
Ahlskog, J.E.3
-
64
-
-
0031004940
-
Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized double-blind multicenter study. Midodrine Study Group
-
Low P.A., Gilden J.L., Freeman R., et al. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized double-blind multicenter study. Midodrine Study Group. JAMA 1997, 277:1046-1051.
-
(1997)
JAMA
, vol.277
, pp. 1046-1051
-
-
Low, P.A.1
Gilden, J.L.2
Freeman, R.3
-
65
-
-
72149119358
-
Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells
-
Luk K.C., Song C., O'Brien P., et al. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A 2009, 106:20051-20056.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 20051-20056
-
-
Luk, K.C.1
Song, C.2
O'Brien, P.3
-
66
-
-
78650416623
-
Differenzialdiagnose der Parkinson-Syndrome mittels MRT
-
Mahlknecht P., Schocke M., Seppi K. Differenzialdiagnose der Parkinson-Syndrome mittels MRT. Nervenarzt 2010, 81:1168-1179.
-
(2010)
Nervenarzt
, vol.81
, pp. 1168-1179
-
-
Mahlknecht, P.1
Schocke, M.2
Seppi, K.3
-
67
-
-
43449108312
-
L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience
-
Mathias C.J. L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience. Clin Auton Res 2008, 18(Suppl 1):25-29.
-
(2008)
Clin Auton Res
, vol.18
, Issue.SUPPL 1
, pp. 25-29
-
-
Mathias, C.J.1
-
68
-
-
27744455451
-
Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia
-
Miller D.W., Johnson J.M., Solano S.M., et al. Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm 2005, 112:1613-1624.
-
(2005)
J Neural Transm
, vol.112
, pp. 1613-1624
-
-
Miller, D.W.1
Johnson, J.M.2
Solano, S.M.3
-
69
-
-
0026115598
-
Environmental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation
-
Nee L.E., Gomez M.R., Dambrosia J., et al. Environmental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation. Clin Auton Res 1991, 1:9-13.
-
(1991)
Clin Auton Res
, vol.1
, pp. 9-13
-
-
Nee, L.E.1
Gomez, M.R.2
Dambrosia, J.3
-
70
-
-
33749461554
-
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy
-
Nicoletti G., Lodi R., Condino F., et al. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain 2006, 129:2679-2687.
-
(2006)
Brain
, vol.129
, pp. 2679-2687
-
-
Nicoletti, G.1
Lodi, R.2
Condino, F.3
-
71
-
-
0036237940
-
Apomorphine as an alternative to sildenafil in Parkinson's disease
-
O'Sullivan J.D. Apomorphine as an alternative to sildenafil in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002, 72:681.
-
(2002)
J Neurol Neurosurg Psychiatry
, vol.72
, pp. 681
-
-
O'Sullivan, J.D.1
-
72
-
-
44949211482
-
Clinical outcomes of progressive supranuclear palsy and multiple system atrophy
-
O'Sullivan S.S., Massey L.A., Williams D.R., et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 2008, 131:1362-1372.
-
(2008)
Brain
, vol.131
, pp. 1362-1372
-
-
O'Sullivan, S.S.1
Massey, L.A.2
Williams, D.R.3
-
73
-
-
33751234531
-
Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy
-
Orimo S., Kanazawa T., Nakamura A., et al. Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol 2007, 113:81-86.
-
(2007)
Acta Neuropathol
, vol.113
, pp. 81-86
-
-
Orimo, S.1
Kanazawa, T.2
Nakamura, A.3
-
74
-
-
34547789387
-
Morphological substrate of autonomic failure and neurohormonal dysfunction in multiple system atrophy: impact on determining phenotype spectrum
-
Ozawa T. Morphological substrate of autonomic failure and neurohormonal dysfunction in multiple system atrophy: impact on determining phenotype spectrum. Acta Neuropathol 2007, 114:201-211.
-
(2007)
Acta Neuropathol
, vol.114
, pp. 201-211
-
-
Ozawa, T.1
-
75
-
-
10344260246
-
The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations
-
Ozawa T., Paviour D., Quinn N.P., et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004, 127:2657-2671.
-
(2004)
Brain
, vol.127
, pp. 2657-2671
-
-
Ozawa, T.1
Paviour, D.2
Quinn, N.P.3
-
77
-
-
37849004924
-
Urinary and erectile dysfunction in multiple system atrophy (MSA)
-
Papatsoris A.G., Papapetropoulos S., Singer C., et al. Urinary and erectile dysfunction in multiple system atrophy (MSA). Neurourol Urodyn 2008, 27:22-27.
-
(2008)
Neurourol Urodyn
, vol.27
, pp. 22-27
-
-
Papatsoris, A.G.1
Papapetropoulos, S.2
Singer, C.3
-
78
-
-
0028339722
-
The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology
-
Papp M.I., Lantos P.L. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994, 117:235-243.
-
(1994)
Brain
, vol.117
, pp. 235-243
-
-
Papp, M.I.1
Lantos, P.L.2
-
79
-
-
0024843373
-
Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration olivopontocerebellar atrophy and Shy-Drager syndrome)
-
Papp M.I., Kahn J.E., Lantos P.L. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989, 94:79-100.
-
(1989)
J Neurol Sci
, vol.94
, pp. 79-100
-
-
Papp, M.I.1
Kahn, J.E.2
Lantos, P.L.3
-
80
-
-
80051780265
-
Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy-parkinsonism
-
Park H.J., Bang G., Lee B.R., et al. Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy-parkinsonism. Cell Transplant 2011, 20:827-835.
-
(2011)
Cell Transplant
, vol.20
, pp. 827-835
-
-
Park, H.J.1
Bang, G.2
Lee, B.R.3
-
81
-
-
29944438923
-
Is sphincter electromyography a helpful investigation in the diagnosis of multiple system atrophy? A retrospective study with pathological diagnosis
-
Paviour D.C., Williams D., Fowler C.J., et al. Is sphincter electromyography a helpful investigation in the diagnosis of multiple system atrophy? A retrospective study with pathological diagnosis. Mov Disord 2005, 20:1425-1430.
-
(2005)
Mov Disord
, vol.20
, pp. 1425-1430
-
-
Paviour, D.C.1
Williams, D.2
Fowler, C.J.3
-
82
-
-
0024474837
-
Multiple system atrophy - the nature of the beast
-
Quinn N. Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry 1989, (Suppl):78-89.
-
(1989)
J Neurol Neurosurg Psychiatry
, Issue.SUPPL
, pp. 78-89
-
-
Quinn, N.1
-
83
-
-
0024836423
-
Prevention of glucose-induced hypotension by the somatostatin analogue octreotide (SMS 201-995) in chronic autonomic failure: haemodynamic and hormonal changes
-
Raimbach S.J., Cortelli P., Kooner J.S., et al. Prevention of glucose-induced hypotension by the somatostatin analogue octreotide (SMS 201-995) in chronic autonomic failure: haemodynamic and hormonal changes. Clin Sci (Lond) 1989, 77:623-628.
-
(1989)
Clin Sci (Lond)
, vol.77
, pp. 623-628
-
-
Raimbach, S.J.1
Cortelli, P.2
Kooner, J.S.3
-
84
-
-
72849145695
-
123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders
-
123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders. Mov Disord 2009, 24(Suppl 2):S732-S741.
-
(2009)
Mov Disord
, vol.24
, Issue.SUPPL 2
-
-
Rascol, O.1
Schelosky, L.2
-
85
-
-
0034064220
-
Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifestation?
-
Sakakibara R., Hattori T., Uchiyama T., et al. Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifestation?. J Neurol Neurosurg Psychiatry 2000, 68:65-69.
-
(2000)
J Neurol Neurosurg Psychiatry
, vol.68
, pp. 65-69
-
-
Sakakibara, R.1
Hattori, T.2
Uchiyama, T.3
-
86
-
-
34748894479
-
Calcium polycarbophil improves constipation in primary autonomic failure and multiple system atrophy subjects
-
Sakakibara R., Yamaguchi T., Uchiyama T., et al. Calcium polycarbophil improves constipation in primary autonomic failure and multiple system atrophy subjects. Mov Disord 2007, 22:1672-1673.
-
(2007)
Mov Disord
, vol.22
, pp. 1672-1673
-
-
Sakakibara, R.1
Yamaguchi, T.2
Uchiyama, T.3
-
87
-
-
0037176815
-
Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD
-
Schocke M.F., Seppi K., Esterhammer R., et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 2002, 58:575-580.
-
(2002)
Neurology
, vol.58
, pp. 575-580
-
-
Schocke, M.F.1
Seppi, K.2
Esterhammer, R.3
-
88
-
-
67249139655
-
SNCA variants are associated with increased risk for multiple system atrophy
-
Scholz S.W., Houlden H., Schulte C., et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 2009, 65:610-614.
-
(2009)
Ann Neurol
, vol.65
, pp. 610-614
-
-
Scholz, S.W.1
Houlden, H.2
Schulte, C.3
-
89
-
-
0033589692
-
Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study
-
Schrag A., Ben Shlomo Y., Quinn N.P. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 1999, 354:1771-1775.
-
(1999)
Lancet
, vol.354
, pp. 1771-1775
-
-
Schrag, A.1
Ben Shlomo, Y.2
Quinn, N.P.3
-
90
-
-
0034620601
-
Differentiation of atypical parkinsonian syndromes with routine MRI
-
Schrag A., Good C.D., Miszkiel K., et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000, 54:697-702.
-
(2000)
Neurology
, vol.54
, pp. 697-702
-
-
Schrag, A.1
Good, C.D.2
Miszkiel, K.3
-
91
-
-
33745869469
-
Health-related quality of life in multiple system atrophy
-
Schrag A., Geser F., Stampfer-Kountchev M., et al. Health-related quality of life in multiple system atrophy. Mov Disord 2006, 21:809-815.
-
(2006)
Mov Disord
, vol.21
, pp. 809-815
-
-
Schrag, A.1
Geser, F.2
Stampfer-Kountchev, M.3
-
92
-
-
38549157541
-
Measuring health-related quality of life in MSA: the MSA-QoL
-
Schrag A., Selai C., Mathias C., et al. Measuring health-related quality of life in MSA: the MSA-QoL. Mov Disord 2007, 22:2332-2338.
-
(2007)
Mov Disord
, vol.22
, pp. 2332-2338
-
-
Schrag, A.1
Selai, C.2
Mathias, C.3
-
93
-
-
0028659025
-
Multiple system atrophy: natural history MRI morphology and dopamine receptor imaging with 123IBZM-SPECT
-
Schulz J.B., Klockgether T., Petersen D., et al. Multiple system atrophy: natural history MRI morphology and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry 1994, 57:1047-1056.
-
(1994)
J Neurol Neurosurg Psychiatry
, vol.57
, pp. 1047-1056
-
-
Schulz, J.B.1
Klockgether, T.2
Petersen, D.3
-
94
-
-
77956828791
-
A case-control study of multiple system atrophy in Korean patients
-
Seo J.H., Yong S.W., Song S.K., et al. A case-control study of multiple system atrophy in Korean patients. Mov Disord 2010, 25:1953-1959.
-
(2010)
Mov Disord
, vol.25
, pp. 1953-1959
-
-
Seo, J.H.1
Yong, S.W.2
Song, S.K.3
-
95
-
-
70549108189
-
Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes
-
Seppi K., Poewe W. Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes. Neuroimaging Clin N Am 2010, 20:29-55.
-
(2010)
Neuroimaging Clin N Am
, vol.20
, pp. 29-55
-
-
Seppi, K.1
Poewe, W.2
-
96
-
-
0037465774
-
Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD but not from the parkinson variant of multiple system atrophy
-
Seppi K., Schocke M.F., Esterhammer R., et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD but not from the parkinson variant of multiple system atrophy. Neurology 2003, 60:922-927.
-
(2003)
Neurology
, vol.60
, pp. 922-927
-
-
Seppi, K.1
Schocke, M.F.2
Esterhammer, R.3
-
97
-
-
33748923842
-
Placebo-controlled trial of riluzole in multiple system atrophy
-
Seppi K., Peralta C., Diem-Zangerl A., et al. Placebo-controlled trial of riluzole in multiple system atrophy. Eur J Neurol 2006, 13:1146-1148.
-
(2006)
Eur J Neurol
, vol.13
, pp. 1146-1148
-
-
Seppi, K.1
Peralta, C.2
Diem-Zangerl, A.3
-
98
-
-
27944436033
-
Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy
-
Shults C.W., Rockenstein E., Crews L., et al. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J Neurosci 2005, 25:10689-10699.
-
(2005)
J Neurosci
, vol.25
, pp. 10689-10699
-
-
Shults, C.W.1
Rockenstein, E.2
Crews, L.3
-
99
-
-
72849160194
-
A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study
-
Shy G.M., Drager G.A. A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study. Arch Neurol 1960, 2:511-527.
-
(1960)
Arch Neurol
, vol.2
, pp. 511-527
-
-
Shy, G.M.1
Drager, G.A.2
-
100
-
-
35348909482
-
P25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy
-
Song Y.J., Lundvig D.M., Huang Y., et al. p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Am J Pathol 2007, 171:1291-1303.
-
(2007)
Am J Pathol
, vol.171
, pp. 1291-1303
-
-
Song, Y.J.1
Lundvig, D.M.2
Huang, Y.3
-
101
-
-
0032584686
-
Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies
-
Spillantini M.G., Crowther R.A., Jakes R., et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998, 251:205-208.
-
(1998)
Neurosci Lett
, vol.251
, pp. 205-208
-
-
Spillantini, M.G.1
Crowther, R.A.2
Jakes, R.3
-
102
-
-
23944510851
-
Animal models of multiple system atrophy
-
Stefanova N., Tison F., Reindl M., et al. Animal models of multiple system atrophy. Trends Neurosci 2005, 28:501-506.
-
(2005)
Trends Neurosci
, vol.28
, pp. 501-506
-
-
Stefanova, N.1
Tison, F.2
Reindl, M.3
-
103
-
-
36949032824
-
Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy
-
Stefanova N., Reindl M., Neumann M., et al. Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy. Mov Disord 2007, 22:2196-2203.
-
(2007)
Mov Disord
, vol.22
, pp. 2196-2203
-
-
Stefanova, N.1
Reindl, M.2
Neumann, M.3
-
104
-
-
41149124377
-
Rasagiline is neuroprotective in a transgenic model of multiple system atrophy
-
Stefanova N., Poewe W., Wenning G.K. Rasagiline is neuroprotective in a transgenic model of multiple system atrophy. Exp Neurol 2008, 210:421-427.
-
(2008)
Exp Neurol
, vol.210
, pp. 421-427
-
-
Stefanova, N.1
Poewe, W.2
Wenning, G.K.3
-
105
-
-
71849092562
-
Multiple system atrophy: an update
-
Stefanova N., Bucke P., Duerr S., et al. Multiple system atrophy: an update. Lancet Neurol 2009, 8:1172-1178.
-
(2009)
Lancet Neurol
, vol.8
, pp. 1172-1178
-
-
Stefanova, N.1
Bucke, P.2
Duerr, S.3
-
108
-
-
0029928921
-
Survival in multiple system atrophy: a study of prognostic factors in 59 cases
-
Testa D., Filippini G., Farinotti M., et al. Survival in multiple system atrophy: a study of prognostic factors in 59 cases. J Neurol 1996, 243:401-404.
-
(1996)
J Neurol
, vol.243
, pp. 401-404
-
-
Testa, D.1
Filippini, G.2
Farinotti, M.3
-
109
-
-
0034606966
-
Prevalence of multiple system atrophy
-
Tison F., Yekhlef F., Chrysostome V., et al. Prevalence of multiple system atrophy. Lancet 2000, 355:495-496.
-
(2000)
Lancet
, vol.355
, pp. 495-496
-
-
Tison, F.1
Yekhlef, F.2
Chrysostome, V.3
-
110
-
-
35948994645
-
Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy
-
Trojanowski J.Q., Revesz T. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 2007, 33:615-620.
-
(2007)
Neuropathol Appl Neurobiol
, vol.33
, pp. 615-620
-
-
Trojanowski, J.Q.1
Revesz, T.2
-
111
-
-
52649175462
-
Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy
-
Ubhi K., Rockenstein E., Mante M., et al. Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy. Neuroreport 2008, 19:1271-1276.
-
(2008)
Neuroreport
, vol.19
, pp. 1271-1276
-
-
Ubhi, K.1
Rockenstein, E.2
Mante, M.3
-
112
-
-
18844476816
-
Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms
-
Vanacore N., Bonifati V., Fabbrini G., et al. Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms. Neurology 2000, 54:114-119.
-
(2000)
Neurology
, vol.54
, pp. 114-119
-
-
Vanacore, N.1
Bonifati, V.2
Fabbrini, G.3
-
113
-
-
18044404432
-
Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms
-
Vanacore N., Bonifati V., Fabbrini G., et al. Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol Sci 2001, 22:97-99.
-
(2001)
Neurol Sci
, vol.22
, pp. 97-99
-
-
Vanacore, N.1
Bonifati, V.2
Fabbrini, G.3
-
114
-
-
20144367968
-
Case-control study of multiple system atrophy
-
Vanacore N., Bonifati V., Fabbrini G., et al. Case-control study of multiple system atrophy. Mov Disord 2005, 20:158-163.
-
(2005)
Mov Disord
, vol.20
, pp. 158-163
-
-
Vanacore, N.1
Bonifati, V.2
Fabbrini, G.3
-
115
-
-
48649109438
-
Risk factors of multiple system atrophy: a case-control study in French patients
-
Vidal J.S., Vidailhet M., Elbaz A., et al. Risk factors of multiple system atrophy: a case-control study in French patients. Mov Disord 2008, 23:797-803.
-
(2008)
Mov Disord
, vol.23
, pp. 797-803
-
-
Vidal, J.S.1
Vidailhet, M.2
Elbaz, A.3
-
116
-
-
0037382294
-
Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy - parkinsonism. Report of four cases
-
Visser-Vandewalle V., Temel Y., Colle H., et al. Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy - parkinsonism. Report of four cases. J Neurosurg 2003, 98:882-887.
-
(2003)
J Neurosurg
, vol.98
, pp. 882-887
-
-
Visser-Vandewalle, V.1
Temel, Y.2
Colle, H.3
-
117
-
-
0035412947
-
Sphincter EMG and differential diagnosis of multiple system atrophy
-
Vodusek D.B. Sphincter EMG and differential diagnosis of multiple system atrophy. Mov Disord 2001, 16:600-607.
-
(2001)
Mov Disord
, vol.16
, pp. 600-607
-
-
Vodusek, D.B.1
-
118
-
-
33845628890
-
Transcranial brain parenchyma sonography in movement disorders: state of the art
-
Walter U., Behnke S., Eyding J., et al. Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med Biol 2007, 33:15-25.
-
(2007)
Ultrasound Med Biol
, vol.33
, pp. 15-25
-
-
Walter, U.1
Behnke, S.2
Eyding, J.3
-
119
-
-
0036241996
-
Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients
-
Watanabe H., Saito Y., Terao S., et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 2002, 125:1070-1083.
-
(2002)
Brain
, vol.125
, pp. 1070-1083
-
-
Watanabe, H.1
Saito, Y.2
Terao, S.3
-
120
-
-
27644577322
-
Placebo-controlled trial of amantadine in multiple-system atrophy
-
Wenning G.K. Placebo-controlled trial of amantadine in multiple-system atrophy. Clin Neuropharmacol 2005, 28:225-227.
-
(2005)
Clin Neuropharmacol
, vol.28
, pp. 225-227
-
-
Wenning, G.K.1
-
121
-
-
0027930620
-
Clinical features and natural history of multiple system atrophy. An analysis of 100 cases
-
Wenning G.K., Ben Shlomo Y., Magalhaes M., et al. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994, 117:835-845.
-
(1994)
Brain
, vol.117
, pp. 835-845
-
-
Wenning, G.K.1
Ben Shlomo, Y.2
Magalhaes, M.3
-
122
-
-
0030986997
-
Multiple system atrophy: a review of 203 pathologically proven cases
-
Wenning G.K., Tison F., Ben Shlomo Y., et al. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997, 12:133-147.
-
(1997)
Mov Disord
, vol.12
, pp. 133-147
-
-
Wenning, G.K.1
Tison, F.2
Ben Shlomo, Y.3
-
123
-
-
0036208772
-
A novel grading scale for striatonigral degeneration (multiple system atrophy)
-
Wenning G.K., Seppi K., Tison F., et al. A novel grading scale for striatonigral degeneration (multiple system atrophy). J Neural Transm 2002, 109:307-320.
-
(2002)
J Neural Transm
, vol.109
, pp. 307-320
-
-
Wenning, G.K.1
Seppi, K.2
Tison, F.3
-
126
-
-
19944428639
-
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)
-
Wenning G.K., Tison F., Seppi K., et al. Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 2004, 19:1391-1402.
-
(2004)
Mov Disord
, vol.19
, pp. 1391-1402
-
-
Wenning, G.K.1
Tison, F.2
Seppi, K.3
-
127
-
-
54849425351
-
Multiple system atrophy: a primary oligodendrogliopathy
-
Wenning G.K., Stefanova N., Jellinger K.A., et al. Multiple system atrophy: a primary oligodendrogliopathy. Ann Neurol 2008, 64:239-246.
-
(2008)
Ann Neurol
, vol.64
, pp. 239-246
-
-
Wenning, G.K.1
Stefanova, N.2
Jellinger, K.A.3
-
129
-
-
28144460717
-
When is Onuf's nucleus involved in multiple system atrophy? A sphincter electromyography study
-
Yamamoto T., Sakakibara R., Uchiyama T., et al. When is Onuf's nucleus involved in multiple system atrophy? A sphincter electromyography study. J Neurol Neurosurg Psychiatry 2005, 76:1645-1648.
-
(2005)
J Neurol Neurosurg Psychiatry
, vol.76
, pp. 1645-1648
-
-
Yamamoto, T.1
Sakakibara, R.2
Uchiyama, T.3
-
130
-
-
15444376598
-
Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration
-
Yazawa I., Giasson B.I., Sasaki R., et al. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 2005, 45:847-859.
-
(2005)
Neuron
, vol.45
, pp. 847-859
-
-
Yazawa, I.1
Giasson, B.I.2
Sasaki, R.3
-
131
-
-
34648813113
-
Multiple system atrophy: alpha-synuclein and neuronal degeneration
-
Yoshida M. Multiple system atrophy: alpha-synuclein and neuronal degeneration. Neuropathology 2007, 27:484-493.
-
(2007)
Neuropathology
, vol.27
, pp. 484-493
-
-
Yoshida, M.1
-
132
-
-
10044272305
-
The effects of water ingestion on orthostatic hypotension in two groups of chronic autonomic failure: multiple system atrophy and pure autonomic failure
-
Young T.M., Mathias C.J. The effects of water ingestion on orthostatic hypotension in two groups of chronic autonomic failure: multiple system atrophy and pure autonomic failure. J Neurol Neurosurg Psychiatry 2004, 75:1737-1741.
-
(2004)
J Neurol Neurosurg Psychiatry
, vol.75
, pp. 1737-1741
-
-
Young, T.M.1
Mathias, C.J.2
-
133
-
-
0037007645
-
Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
-
Zhu S., Stavrovskaya I.G., Drozda M., et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002, 417:74-78.
-
(2002)
Nature
, vol.417
, pp. 74-78
-
-
Zhu, S.1
Stavrovskaya, I.G.2
Drozda, M.3
|